Barr, Par Settle With Valeant Over Epilepsy Drug
Barr Pharmaceuticals Inc. and Par Pharmaceutical Cos. Inc. have finalized a settlement with Valeant Pharmaceuticals North America over a generic version of Valeant's epileptic seizure treatments Diastat and Diastat AcuDial....To view the full article, register now.
Already a subscriber? Click here to view full article